Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Clin Gastroenterol ; 45(5): 468-73, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-20661153

RESUMEN

Fanconi syndrome results from generalised renal tubular toxicity and, owing to phosphate wasting can cause hypophosphataemic osteomalacia. Large clinical trials advocated the safety of adefovir dipivoxil at a daily dose of 10 mg, the standard dose given to patients with hepatitis B. We diagnosed Fanconi syndrome in conjunction with severe osteomalacia in 2 hepatitis B-positive patients on standard-dose adefovir therapy. The first patient was a 40-year-old male with a 5 month history of bone pain involving his knees, ankles, and ribs. He had been receiving adefovir dipivoxil for 27 months before the development of hypophosphataemia, urinary phosphate wasting, and aminoaciduria. These abnormalities resolved within weeks of discontinuation of adefovir dipivoxil and supplementation with elemental phosphate, calcium carbonate, and cholecalciferol. The second patient was a 53-year-old female with a 6 month history of lethargy, cachexia, and generalized bone pain. She had been receiving adefovir for 64 months before the development of these symptoms. She had hypophosphataemia, hypocalcaemia, metabolic acidosis, and severe vitamin D deficiency, but initially no urinary phosphate wasting. Four months of high-dose cholecalciferol supplementation unmasked her Fanconi syndrome including significant urinary phosphate wasting. The patient improved within weeks of discontinuation of adefovir and supplementation with elemental phosphate, calcium carbonate, and calcitriol. Despite large clinical trials advocating the safety of adefovir dipivoxil at 10-mg daily, long-term use of this agent may be nephrotoxic and in rare cases, cause Fanconi syndrome and severe hypophosphataemic osteomalacia. Clinicians prescribing this drug should be aware of this potential complication.


Asunto(s)
Adenina/análogos & derivados , Antivirales/efectos adversos , Hepatitis B/tratamiento farmacológico , Organofosfonatos/efectos adversos , Osteomalacia/inducido químicamente , Adenina/administración & dosificación , Adenina/efectos adversos , Adulto , Antivirales/administración & dosificación , Densidad Ósea/efectos de los fármacos , Síndrome de Fanconi/inducido químicamente , Síndrome de Fanconi/diagnóstico , Femenino , Virus de la Hepatitis B/efectos de los fármacos , Humanos , Hipofosfatemia/inducido químicamente , Hipofosfatemia/diagnóstico , Hipofosfatemia/diagnóstico por imagen , Masculino , Persona de Mediana Edad , Organofosfonatos/administración & dosificación , Osteomalacia/diagnóstico , Osteomalacia/diagnóstico por imagen , Radiografía , Cintigrafía , Imagen de Cuerpo Entero
3.
ANZ J Surg ; 77(4): 297-304, 2007 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-17388841

RESUMEN

Parathyroid cysts are rare and even more rarely cause a neck mass resembling a goitre. Such large parathyroid cysts may involve the mediastinum, growing to a sufficient size to produce symptoms related to obstruction, and if functioning, primary hyperparathyroidism. Parathyroid cysts should be considered in the list of differential diagnoses of anterior neck masses to allow for appropriate preoperative investigation to avoid unnecessary confusion at the time of operation. We report a case where a functioning parathyroid cyst presented as a retrosternal goitre to emphasize the potential pitfalls associated with their diagnosis and management.


Asunto(s)
Quistes/diagnóstico , Quistes/cirugía , Bocio Subesternal/diagnóstico , Bocio Subesternal/cirugía , Enfermedades de las Paratiroides/diagnóstico , Enfermedades de las Paratiroides/cirugía , Anciano , Quistes/patología , Diagnóstico Diferencial , Bocio Subesternal/patología , Humanos , Masculino , Enfermedades de las Paratiroides/patología , Tiroidectomía , Tomografía Computarizada por Rayos X , Ultrasonografía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...